Trial · NCT03355209
Adverse events848
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 848
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Mitral valve incompetence | Cardiac disorders | Part 1: Cohort A- Placebo | 0 | 87 | 0 |
| other | Mitral valve incompetence | Cardiac disorders | Part 1: Cohort A- ZX008 0.2 mg/kg/Day | 0 | 89 | 0 |
| other | Mitral valve incompetence | Cardiac disorders | Part 1: Cohort A- ZX008 0.8 mg/kg/Day | 0 | 87 | 0 |
| other | Mitral valve incompetence | Cardiac disorders | Part 2: Cohort A- Overall | 0 | 247 | 0 |
| other | Mitral valve incompetence | Cardiac disorders | Part 1: Cohort B- Placebo | 0 | 11 | 0 |
| other | Mitral valve incompetence | Cardiac disorders | Part 1: Cohort B- ZX008 0.2 mg/kg/Day | 1 | 11 | 1 |
| other | Mitral valve incompetence | Cardiac disorders | Part 1: Cohort B- ZX008 0.8 mg/kg/Day | 0 | 11 | 0 |
| other | Mitral valve incompetence | Cardiac disorders | Part 2: Cohort B- Overall | 0 | 32 | 0 |
| other | Hyperprolactinaemia | Endocrine disorders | Part 1: Cohort A- Placebo | 0 | 87 | 0 |
| other | Hyperprolactinaemia | Endocrine disorders | Part 1: Cohort A- ZX008 0.2 mg/kg/Day | 0 | 89 | 0 |
| other | Hyperprolactinaemia | Endocrine disorders | Part 1: Cohort A- ZX008 0.8 mg/kg/Day | 3 | 87 | 3 |
| other | Hyperprolactinaemia | Endocrine disorders | Part 2: Cohort A- Overall | 3 | 247 | 4 |
| other | Hyperprolactinaemia | Endocrine disorders | Part 1: Cohort B- Placebo | 0 | 11 | 0 |
| other | Hyperprolactinaemia | Endocrine disorders | Part 1: Cohort B- ZX008 0.2 mg/kg/Day | 0 | 11 | 0 |
| other | Hyperprolactinaemia | Endocrine disorders | Part 1: Cohort B- ZX008 0.8 mg/kg/Day | 1 | 11 | 1 |
| other | Hyperprolactinaemia | Endocrine disorders | Part 2: Cohort B- Overall | 0 | 32 | 0 |
| other | Diplopia | Eye disorders | Part 1: Cohort A- Placebo | 0 | 87 | 0 |
| other | Diplopia | Eye disorders | Part 1: Cohort A- ZX008 0.2 mg/kg/Day | 0 | 89 | 0 |
| other | Diplopia | Eye disorders | Part 1: Cohort A- ZX008 0.8 mg/kg/Day | 0 | 87 | 0 |
| other | Diplopia | Eye disorders | Part 2: Cohort A- Overall | 0 | 247 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03355209/events